125 related articles for article (PubMed ID: 22517063)
1. [Individualized tumor therapy and status quo in melanoma].
Bauer S; Schmidberger H; Trefzer U
Onkologie; 2012; 35 Suppl 2():2-6. PubMed ID: 22517063
[No Abstract] [Full Text] [Related]
2. Nivolumab success in untreated metastatic melanoma.
Wilkinson E
Lancet Oncol; 2015 Jan; 16(1):e9. PubMed ID: 25638562
[No Abstract] [Full Text] [Related]
3. The systemic treatment of advanced cutaneous melanoma.
Logan TF
Facial Plast Surg Clin North Am; 2003 Feb; 11(1):75-85. PubMed ID: 15062290
[No Abstract] [Full Text] [Related]
4. [Adjuvant systemic treatment of melanoma].
Kähler KC; Egberts F; Hauschild A; Mohr P
Hautarzt; 2011 Jun; 62(6):414, 416-22. PubMed ID: 21656113
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant interferon therapy for melanoma.
Hancock B; Wheatley K; Ives N; Gore M
J Clin Oncol; 2005 Apr; 23(10):2431; author reply 2431-2. PubMed ID: 15800339
[No Abstract] [Full Text] [Related]
6. Immunity unleashed in melanoma.
Erdmann MK
Lancet Oncol; 2010 Feb; 11(2):108-9. PubMed ID: 20152761
[No Abstract] [Full Text] [Related]
7. [Not Available].
Eigentler TK
J Dtsch Dermatol Ges; 2015 Oct; 13(10):1055-6. PubMed ID: 26408485
[No Abstract] [Full Text] [Related]
8. Ipilimumab for advanced metastatic melanoma.
Starz H
Expert Opin Biol Ther; 2012 Aug; 12(8):981-2. PubMed ID: 22690756
[No Abstract] [Full Text] [Related]
9. Treatment of brain metastases in patients with melanoma.
Fisher R; Larkin J
Lancet Oncol; 2012 May; 13(5):434-5. PubMed ID: 22456430
[No Abstract] [Full Text] [Related]
10. [Editorial].
Schilling B; Schadendorf D
J Dtsch Dermatol Ges; 2016 Jan; 14(1):1-2. PubMed ID: 26713629
[No Abstract] [Full Text] [Related]
11. Ipilimumab in patients with melanoma and brain metastases.
Nieder C
Lancet Oncol; 2012 Jul; 13(7):e277; author reply e277-8. PubMed ID: 22748259
[No Abstract] [Full Text] [Related]
12. [Diversity and individualization of cancer treatment].
Dietrich PY
Rev Med Suisse; 2011 May; 7(296):1123-4. PubMed ID: 21721200
[No Abstract] [Full Text] [Related]
13. Melanoma vaccines: possible progress after years of frustration?
Schmidt C
J Natl Cancer Inst; 2009 Feb; 101(3):140-1. PubMed ID: 19176461
[No Abstract] [Full Text] [Related]
14. The place of PD-1 inhibitors in melanoma management.
Bowyer S; Lorigan P
Lancet Oncol; 2015 Aug; 16(8):873-4. PubMed ID: 26115798
[No Abstract] [Full Text] [Related]
15. [Pharmacologic therapy of melanoma of the skin].
Dement'eva NP; Koroleva LA
Sov Med; 1987; (2):49-53. PubMed ID: 3576316
[No Abstract] [Full Text] [Related]
16. Ipilimumab Adjuvant Therapy in Melanoma.
Copur MS; Ramaekers R; Crockett D
N Engl J Med; 2017 Jan; 376(4):398-9. PubMed ID: 28125194
[No Abstract] [Full Text] [Related]
17. Ipilimumab Adjuvant Therapy in Melanoma.
Ianiro G; Gasbarrini A; Cammarota G
N Engl J Med; 2017 Jan; 376(4):398. PubMed ID: 28125193
[No Abstract] [Full Text] [Related]
18. Ipilimumab Adjuvant Therapy in Melanoma.
Eggermont AMM; Suciu S; Testori A
N Engl J Med; 2017 Jan; 376(4):399. PubMed ID: 28121506
[No Abstract] [Full Text] [Related]
19. [Journal-Club].
Rupec RA
J Dtsch Dermatol Ges; 2014 Nov; 12(11):1064. PubMed ID: 25382573
[No Abstract] [Full Text] [Related]
20. [Melanoma: a new therapeutic era].
Berthod G; Homicsko K; Bouchaab H; Matter M; Cerottini JP; Guggisberg D; Speiser D; Leyvraz S; Michielin O
Rev Med Suisse; 2011 May; 7(296):1126-30. PubMed ID: 21721201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
